Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms
Mohamed A.M. El Gendy, Anatoly A. Soshilov, Michael S. Denison, Ayman O.S. El-KadiVolume:
50
Year:
2012
Language:
english
DOI:
10.1016/j.fct.2011.10.052
File:
PDF, 953 KB
english, 2012